Sponsor Pipeline

NOBO Medicine Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06737250 NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL Primary CNS Lymphoma (PCNSL) Recruiting
Phase 1
NCT07114367 NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma Non Hodgkin Lymphoma (NHL) Recruiting
Disease Areas
Non-Hodgkin Lymphoma (1)
Get alerts when NOBO Medicine's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free